Sherri Johnson

Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings

Beatrice A. Chen, Lori Panther, Mark A. Marzinke et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2015 · 106 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Mucosal effects of tenofovir 1% gel

Florian Hladik, Adam Burgener, Lamar Ballweber et al. · eLife · 2015 · 67 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel

Ross Cranston, Javier R. Lama, Barbra A. Richardson et al. · Clinical Infectious Diseases · 2016 · 61 citations · Full text

Public Health, Pharmacotherapy, Sexuality Studies +15

Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial

Gonasagrie Nair, Connie Celum, Daniel Szydlo et al. · The Lancet HIV · 2023 · 60 citations · Full text

Public Health, Infectious Disease Control, Pharmacotherapy +17

High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women

Alex Carballo‐Diéguez, Iván C. Balán, William Brown et al. · PLoS ONE · 2017 · 48 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14